Detalhe da pesquisa
1.
New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer.
Int J Mol Sci
; 24(5)2023 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36902351
2.
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
Amino Acids
; 49(3): 517-528, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27761756
3.
Endothelial progenitor cells, defined by the simultaneous surface expression of VEGFR2 and CD133, are not detectable in healthy peripheral and cord blood.
Cytometry A
; 89(3): 259-70, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26305912
4.
A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).
BMC Cancer
; 16: 69, 2016 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26857924
5.
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
BMC Cancer
; 16(1): 918, 2016 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27884140
6.
Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).
BMC Cancer
; 14: 875, 2014 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25421252
7.
New perspective for an old antidiabetic drug: metformin as anticancer agent.
Cancer Treat Res
; 159: 355-76, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24114491
8.
Paper-based electrochemical device for early detection of integrin αvß6 expressing tumors.
Commun Chem
; 7(1): 60, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514757
9.
Tissue transglutaminase: a new target to reverse cancer drug resistance.
Amino Acids
; 44(1): 63-72, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22130737
10.
Caveolin-1 overexpression is associated with simultaneous abnormal expression of the E-cadherin/α-ß catenins complex and multiple ErbB receptors and with lymph nodes metastasis in head and neck squamous cell carcinomas.
J Cell Physiol
; 227(9): 3344-53, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22213373
11.
Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors.
Cancers (Basel)
; 14(3)2022 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158962
12.
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
J Exp Clin Cancer Res
; 41(1): 83, 2022 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35241126
13.
Plasma metabolomics, lipidomics and cytokinomics profiling predict disease recurrence in metastatic colorectal cancer patients undergoing liver resection.
Front Oncol
; 12: 1110104, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36713567
14.
Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells.
Proteomics
; 11(18): 3725-42, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21761561
15.
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.
J Cell Physiol
; 226(9): 2378-90, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21660961
16.
HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer.
Mol Oncol
; 15(4): 1005-1023, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33331136
17.
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA Netw Open
; 4(7): e2118475, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34309665
18.
Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance.
Front Cell Dev Biol
; 8: 732, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33015030
19.
Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
J Exp Clin Cancer Res
; 39(1): 213, 2020 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33032653
20.
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol.
Ther Adv Med Oncol
; 12: 1758835920929589, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32849914